Jesus Leal

Head of Sales Biologics, Sun Pharma

Jesus Leal is a Pharmaceutical Industry Executive with 38 years of varied experiences.

Most recently at SUN Pharma, Jesus is the Head of Sales for Biologics, focusing on moderate/severe psoriasis. Prior to SUN, Jesus was at Novartis where he managed $2B of sales in the Respiratory Division. Previously he was Vice President and Head of the US General Medicines Early Development, Strategy, BD&L where he was responsible for the development of overall strategy and value optimization for new products and BD&L assets.

Jesus has experience in multiple therapeutic areas including Critical Care, CV, Respiratory, Infectious Diseases and Transplant.

Before Novartis, Jesus was the President of IVAX Labs (now Teva). During his 34 years of Pharma service, Jesus has also worked at Roche Labs and Schering Plough.

Jesus holds a Bachelor of Science degree from Rutgers College of Pharmacy and a Master of Business Administration from Nova University.